Cedarburg Hauser Pharmaceuticals Scientists
Our scientists have extensive experience successfully working with a wide range of molecules, types of chemistry reactions and types of controlled substances. Our chemists have developed some of the most successful APIs on the market today and can help you:
- Develop your target compounds
- Qualify and validate your existing processes
- Enhance and optimize your processes
- Scale up your API for toxicity trials, all phases of your clinical trials and finally to commercialization.
Scientific Leadership Team
Our scientific leadership team is comprised of some of the most experienced, accomplished and recognized scientists working to develop processes and analytical methods for active pharmaceutical ingredients (APIs) and pharmaceutical intermediates today.
Our experienced scientific leadership team includes:
John Lynch, Ph.D. – Chief Scientific Officer
Paul Zizelman – Director of Scientific Operations
Jonathan Pease, Ph.D. – Senior Scientist
Rafail Usatinsky, Ph.D. – Analytical Services Manager
Robert Vicente – Director of Quality
Our Scientists & Their Experience
Scientific Operations
Paul Zizelman – Director of Scientific Operations
Research & Development Scientists
John Lynch, Ph.D. – Chief Scientific Officer
John Cabaj – Senior Scientist
Xiong Fu, Ph.D. – Senior Chemist
Jeff McGilvra, Ph.D. – Senior Scientist
Jonathan Pease, Ph.D. – Senior Scientist
Catherine Smith, Ph.D. – Senior Scientist
Kevin Wirtz, Ph.D. – Senior Scientist
Tom Benson – Scientist
Jeff Hutchison – Scientist
Tony LePine, MS – Associate Scientist
Analytical Chemists
Rafail Usatinsky, Ph.D. – Analytical Services Manager
Lijie Cui, Ph.D. – Senior Analytical Scientist
Luke Hergert, MS – Analytical Chemist II
Tim Feider – Analytical Chemist
Rachana Sachwani, Ph.D. – Analytical Chemist